Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E. Musch

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasmaH K Osterheld, E Musch, G E von Unruh, et al.
Klinische Wochenschrift|May 17, 1982
[Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)]E Musch, M Eichelbaum, J K Wang, et al.
Seminars in Oncology|April 1, 1992
Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II studyW Hiddemann, C Ruelfs, C Ottensmeier, et al.
Clinical Chemistry|February 5, 2000
Comparison of three methods for measuring LDL resistance against copper-induced oxidationP G Scheffer, S J Bakker, E E Musch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assayM M Oppitz, E Musch, M Malek, et al.
Die Medizinische Welt|June 17, 1983
[Intravenous rifampicin therapy in open tuberculosis]U Loos, E Musch, K G Mackes, et al.
Die Medizinische Welt|June 25, 1982
[Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver]E Musch, M Eichelbaum, J K Wang, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 13, 2022
Supplying the pipeline of peer review: A call to engage new practitionersTyler A Vest, Carolyn M Bell, Megan E Adelman, et al.
Praxis Und Klinik Der Pneumologie|October 1, 1983
[Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis]U Loos, E Musch, K G Mackes, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1988
A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasmaH K Osterheld, E Musch, G E von Unruh, et al.
Klinische Wochenschrift|May 17, 1982
[Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)]E Musch, M Eichelbaum, J K Wang, et al.
Seminars in Oncology|April 1, 1992
Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II studyW Hiddemann, C Ruelfs, C Ottensmeier, et al.
Clinical Chemistry|February 5, 2000
Comparison of three methods for measuring LDL resistance against copper-induced oxidationP G Scheffer, S J Bakker, E E Musch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assayM M Oppitz, E Musch, M Malek, et al.
Die Medizinische Welt|June 17, 1983
[Intravenous rifampicin therapy in open tuberculosis]U Loos, E Musch, K G Mackes, et al.
Die Medizinische Welt|June 25, 1982
[Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver]E Musch, M Eichelbaum, J K Wang, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 13, 2022
Supplying the pipeline of peer review: A call to engage new practitionersTyler A Vest, Carolyn M Bell, Megan E Adelman, et al.
Praxis Und Klinik Der Pneumologie|October 1, 1983
[Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis]U Loos, E Musch, K G Mackes, et al.
Pageof 7